We have demonstrated that MBD1 promoted the progression of gastric cancer by recruiting HDAC3 to form a complex, silencing the expression of anti-tumor miR-5701, and increasing the expression of the miR-5701 targets FGFR2. Here, FGFR2 is linked to gastric cancer.